Man 'will not forgive' Rotherham Hospital for wife's death
A man whose wife died three weeks after a specialised procedure to remove gallstones has said he can "never forgive" Rotherham Hospital for the poor care she received.Valerie Birkill, 73, from Bolton-upon-Dearne, died after undergoing an endoscopic retrograde cholangiopancreatography (ERCP), which involved passing a flexible tube with a camera down her throat.Her husband Garry Burkill spoke out after NHS Trust documents revealed 58 patients had received "substandard" care from the service between 2016-21, including 25 who "suffered some degree of harm".Rotherham Hospital NHS Foundation Trust has apologised and said the care provided to some patients was "not at the level we strive for".
Mrs Birkill underwent her ERCP on 1 October 2020, with the procedure lasting just eight minutes.Despite complaining of stomach pains, the retired hairdresser was discharged an hour later and had to be brought back into hospital by ambulance that night.The mother of three and grandmother of seven was later diagnosed with a perforated bowel and went on to develop sepsis before her death on 24 October 2020.The Trust later admitted "failings with regards to the consenting process for the ERCP" and that Mrs Birkill had been "prematurely discharged".It also admitted "on a balance of probability" that with "appropriate care" Mrs Birkill would have "survived and made a full recovery".Mr Birkill, 78, said: "The impact has been massive, we just loved Val so much, and we'd do anything to have her back."We've always known there was something drastically wrong in the whole system, and my heart goes out to anyone who's had to suffer the same as me and my family."
The ERCP procedure, which combines X-ray and endoscopy, comes with known risks and is used to diagnose and treat problems in the liver, gallbladder, bile ducts and pancreas.However, hospital documents show the ERCP service at Rotherham Hospital was suspended in July 2021 following "a cluster of adverse incidents and complications".From 2016, the specialised procedure had been carried out almost exclusively by a single consultant nurse at the hospital.An initial review, published by the Royal College of Physicians in 2023, found that this "isolated practice" had "not provided high standards of performance and safety", resulting in a higher-than-expected complication rate.Problems included inadequate recording of informed consent, deficiencies in ERCP reports and poor radiological documentation.A further review by independent medical experts was established to look at all cases between 2016-21 where the patient had died or there were complications within 30 days of the procedure.In total, 68 cases were looked at in detail with failings in care identified in relation to 58 of them, including 25 where there was "evidence of harm".The report states "it's difficult to be certain that deficiencies in care were always the cause of harm" given the known complications of the procedure but that the overall risk would likely have increased.
Sinead Rollinson-Hayes, a solicitor with Irwin Mitchell, the law firm that represented the Birkill family, said: "There were multiple failings of care in Val's case, which sadly identified that she would be here today but for those failings in care."But reading this report is even more concerning because it is on such a wider scale."The nurse consultant in question is subject to an investigation by the Nursing and Midwifery Council and has interim conditions in place on his ability to practice.Dr Jo Beahan, medical director for the Rotherham NHS Foundation Trust, said: "We apologise unreservedly to patients and their families affected by the failures identified in the ERCP service review. "The care provided to some of the patients who underwent the procedure was not at the level that we strive for."Dr Beahan added: "The Trust has contacted the patients or their relatives whose care has been independently reviewed, including those where no harm was found. "We have apologised and explained the findings of the review. "We will continue to support patients and families on an individual basis to ensure they have the opportunity to understand the care they or their relative received."We are aware that this may cause concern for other patients who have been treated at the Trust. "Anyone with concerns about their care in endoscopy can contact the Trust's Patient Advice and Liaison Service (PALS) on your.experience@nhs.net or 01709 424461."
Listen to highlights from South Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
21 minutes ago
- BBC News
Coventry researchers find ice baths make dippers eat more
Ice baths and plunges into cold lakes and rivers could make aficionados eat more, university researchers have Coventry University team believes appetite is affected by something called the "after-drop", where people's core body temperature continues falling even after they of the brain which sense changes in body temperature and energy levels may cause bathers to crave more food as a natural response, they David Broom said the findings conflicted with popular thinking that icy dips could help with weight loss. Cold water swimming and ice baths have exploded in popularity in recent years, with proponents arguing their benefits for a range of phenomena, from burning extra calories, to improved mental health. Prof Bloom led tests on their impact on appetite and food intake, along with PhD student Marie Grigg from Coventry University's Research Centre for Physical Activity, Sport and Exercise study involved 10 men and five women, who were all healthy and active, spending 30 minutes submerged in cold water, warm water, or sitting in a room at 26C, in tests carried out over several researchers found those in the cold water - kept at a temperature of 16C - ate about 240 extra calories afterwards compared to those in 35C water or at room temperature."Ice baths and cold dips have become really popular; with many people hoping they'll help with weight loss," Prof Bloom said."Interestingly, people didn't say they felt hungrier during or after the cold water - they just ate more."Ms Grigg said more research was needed on the after-drop effect to determine whether repeated cold-water dunks could lead to long-term weight gain."Our findings show it is important to put strategies in place to avoid over-eating after cold water immersion," she added. Follow BBC Coventry & Warwickshire on BBC Sounds, Facebook, X and Instagram.
Telegraph
27 minutes ago
- Telegraph
Why cannabis edibles are worse than smoking
Popped after pudding at middle-class dinner parties or even nibbled on for a night on the sofa, edibles have become the socially acceptable face of cannabis consumption, particularly in gummy form. And the appetite for them shows no signs of being sated. Around one in 14 UK adults has tried edible types of cannabis, the most-used drug in England and Wales since records began in 1995, with the black market for the drug now worth an estimated £2.6 billion each year. Yet the latest research may make those who casually pair them with wine want to rethink. A study from the University of California, San Francisco (UCSF) has for the first time shown that the heart health risks caused by these brightly coloured gummies are aligned with those suffered by cigarette smokers – and worse than those who actually smoke cannabis. Participants in the study who consumed edibles three times a week saw their vascular function fall by around half; while their risk of premature heart disease was increased, too. Other side effects can include spikes in blood pressure, depression and anxiety, among many others. The results are particularly concerning given the rise in people consuming cannabis in non-smokable forms, such as edibles, which has almost doubled in the past eight years, according to the US Centers for Disease Control and Prevention. (Their report last year found that this applied to 41.6 per cent of users, compared to 24.5 per cent in 2016). UK police forces have warned that the gummies are often packaged as sweets and doled out to young people. There has also been a 'significant increase' in hospitalisations for children under-six due to inadvertently consuming their parents' supply and mistaking them for normal sweeties, according to research published in Pediatrics, with almost 90 per cent of cases occurring within the home. 'The rise in cannabis edible use is something I've increasingly noticed, particularly over the last couple of years,' says GP Dr Deepali Misra-Sharp – and 'it's not limited to younger adults either. I've seen growing interest among midlife and older patients, especially those managing chronic pain, insomnia, or anxiety,' she explains. 'Many are drawn to edibles because they're seen as more discreet and 'safer' than smoking cannabis — but that assumption doesn't always hold up.' Skip to: What are cannabis edibles? How do edibles affect the body? How do edibles affect the brain? What exactly are cannabis edibles? Edible cannabis products vary enormously, both in form and content. Common types are gummies (often shaped like teddy bears or worms), along with cakes, crisps and brownies. Some contain CBD (or cannabidiol), the chemical compound extracted from the cannabis plant that does not trigger a psychoactive response or create a 'high.' (Such products are legal in the UK, provided they contain less than 0.2 per cent THC.) More commonly, edibles are laced with THC, or tetrahydrocannabinol – the psychoactive component of cannabis that is illegal in the UK, which carries the greater health risks. Despite regulations, 'it's extremely easy to get it online in a few clicks,' says Dr Niall Campbell, addiction specialist and consultant at the Priory. Edibles, across the demographics, he says, are seen as ''acceptable'; it doesn't seem as harmful to be taking a colourful sweetie' when compared to smoking a joint. While the absence of inhalation may improve the odds for lung-related issues, edibles are unregulated in the UK. With no standard level of THC content within each gummy – meaning some edibles might be far stronger than others – there is also 'no oversight of contaminants, and no reliable labelling,' says Dr Misra-Sharp. 'That makes dose titration [a technique used to determine the concentration of the chemicals] incredibly difficult and adds to the potential for harm' as users might not know how strong each edible is. How do they affect the body? Symptoms can include palpitations and tachycardia, sometimes mistaken for panic attacks; spikes in blood pressure or hypertension (which can elevate risk of heart attack, kidney disease and stroke); dizziness and chest pains, anxiety and insomnia (especially among those who use edibles before bed as a sleep aid). Along with the UCSF research, cardiac issues have been repeatedly linked to regular marijuana use, including in a study of 435,000 adults published last year. Whether smoked, vaped or eaten, using the drug daily was connected to a 25 per cent higher risk of heart attack, and 42 per cent greater likelihood of stroke. Dr Misra-Sharp adds that among her patients, dosing is a major issue when it comes to edibles, as they are so easy to over-consume. Many have displayed 'no real understanding of the dosing [or] onset time' – which can run into several hours, unlike the more immediate effects of smoking the drug. The effects of edibles also typically last much longer. In some cases she has seen, patients have 'consumed multiple doses too quickly because they 'didn't feel anything', which has led to quite unpleasant episodes', such as 'intense anxiety, disorientation, vomiting, racing heart, and in some cases, temporary psychosis or paranoia'. These can be exacerbated either by consuming edibles on an empty stomach, or as a result of THC being fat-soluble – leading to increased absorption when consumed via fatty foods, such as the sweets and cakes it is often contained in. Another potential risk factor is how these edibles may adversely affect medication being taken for existing conditions – 'particularly in more vulnerable groups like older adults, or those taking medications such as beta-blockers, anticoagulants, or antidepressants'. THC has been found to interact with close to 400 prescription medications, such as antidepressants and blood-thinners, while even taking CBD can affect more than 540 – something that is typically little understood by edible consumers. Dr Misra-Sharp says: 'GPs need to start asking about cannabis use more routinely – not just smoking, but edibles too – and have honest, harm-reduction based conversations with our patients.' How do they affect the brain? While THC initially offers a dopamine high, over time, consumption can blunt the brain's reward systems, leading to a raised likelihood of depression, suicidal thoughts and mood swings. It can also impact the ability to form new memories, and hamper how information is processed. Adolescent users may endure greater harm from edible overconsumption, as the brain continues to develop until we reach our mid-20s. Dr Campbell says he has seen more people presenting with cannabis-induced mental health issues due to the seeming omnipresence of the drug. Multiple health services across the UK have linked the rise in patients dealing with psychosis to cannabis use, which they say accounts for around a quarter of all admissions; a Canadian study published earlier this year showed that growing potency of the drug had triggered a surge in cases of schizophrenia, too. The only real way to prevent it taking a serious toll is 'stopping it, if it's not too late'. Sufferers can't work, they can't sustain a relationship, Dr Campbell explains. 'It can lead to violence, if you think someone's coming to get you. Patients flee imagined pursuers, jumping out of buildings and jumping in front of traffic as a result of paranoia. It means they're not productive members of society.' Estimates have put the number of users affected by cannabis-induced paranoid delusions at 6 per cent – and it is the long-term damage that is particularly concerning, Dr Campbell says, due to the difficulty in treating the condition. Sufferers are poorly served by antipsychotic medication, he adds, citing one patient whose issues are 'kept at bay slightly by medication, but he's still paranoid and thinks everybody knows what he's thinking. That's a pretty sad, isolated kind of life.'
Daily Mirror
35 minutes ago
- Daily Mirror
Anyone with hay fever told don't take Kenalog over safety concerns
The National Pharmacy Association (NPA) said people should not buy Kenalog, which can be advertised on social media sites or by salons and beauty clinics The National Pharmacy Association (NPA) has issued a warning against purchasing Kenalog, a drug that is often advertised on social media platforms and by beauty salons and clinics. There are growing concerns that many people are resorting to this drug after discovering it online, despite serious safety issues and the fact that it's not licensed by the NHS. The NPA, which represents over 6,000 independent community pharmacies, has noted an increase in enquiries about Kenalog from healthcare professionals. The organisation is worried that medication procured from unregulated sellers could be counterfeit and pose a significant risk to patient safety. The NHS no longer prescribes or administers Kenalog for hay fever, as their guidelines have determined that the potential risks outweigh the benefits of the treatment. Kenalog injections function by temporarily suppressing the immune system. The injection contains a steroid to reduce inflammation and alleviate symptoms, reports Surrey Live. However, this treatment is not suitable for individuals with mild hay fever symptoms, as it may weaken the immune system, making patients more susceptible to other infections, such as flu, chickenpox, and shingles. Known side effects of the drug include elevated blood pressure, dizziness, severe abdominal pain, depression and mood swings. In the UK, Kenalog is a prescription-only medicine and is not licensed for the treatment of hay fever. The product contains triamcinolone acetonide, a steroid injection licensed for treating conditions such as arthritis but not for hay fever. A joint enforcement notice regarding the advertisement of Kenalog injections was published in 2022 by the MHRA and CAP, instructing all entities that offer Kenalog for hay fever to stop advertising it on social media and their websites. NPA revealed that a proportion of the medication available online are bogus or do not meet UK safety and quality standards, or could be replaced with other drugs. Based on a snapshot survey of more than 350 pharmacies, NPA found 45% have had recent inquiries about using Kenalog for hay fever, while 96% reported a notable surge in patients seeking help for hay fever symptoms since early April. Olivier Picard, NPA chairman, said: "We know that hay fever season is well and truly upon us and as these findings show, pharmacies are reporting increased numbers of patients visiting them to help treat their symptoms. "Kenalog is not licensed in the UK for the treatment of hay fever and we are clear that patients should not seek it online or request it from their community pharmacy. "We're urging people to avoid using unlicensed treatments, which could pose a serious risk to their health, and instead speak with their pharmacist about other options for managing hay fever symptoms. "Pharmacists are well placed to provide safe licensed alternatives, such as antihistamines or steroid nasal sprays. "Medication from unregulated sellers could be fake, swapped for an alternative medication and not meet rigorous safety standards we have in the UK. "Instead, patients experiencing hay fever should visit their local pharmacy on their doorstep, who can quickly and safely provide treatments to relieve their symptoms. "If people are unsure about medication bought online, they should check with their pharmacist." The NPA is also calling for regulators to reinstate rules that necessitate a public list of regulated online UK medicine sellers. These requirements were part of previous EU regulations but were discarded when the UK exited the EU. The NPA contends that patients should be able to easily identify a regulated online pharmacy and steer clear of sellers who are not regulated in the UK. Mr Picard believes that reinstating the previous rules would "provide a helpful tool for patients to understand how to find a regulated, safe online pharmacy".
